Neoplastic macrovascular invasion represents an independent risk factor for dismal survival in sorafenib treatment for hepatocellular carcinoma

Original Article

|Open Access
Article Access Statistics
  • Viewed

    965

  • Downloaded

    66

Table of Contents
Hepatoma Research Print ISSN: 2394-5079; Online ISSN: 2454-2520
Partners
Copyright © 2018 OAE Publishing Inc. All Rights Reserved.